Baxter International Inc. (BAX)
NYSE: BAX · Real-Time Price · USD
16.68
-0.10 (-0.60%)
At close: Apr 2, 2026, 4:00 PM EDT
16.61
-0.07 (-0.42%)
After-hours: Apr 2, 2026, 7:53 PM EDT
Baxter International Revenue
In the year 2025, Baxter International had annual revenue of $11.24B with 5.72% growth. Baxter International had revenue of $2.97B in the quarter ending December 31, 2025, with 8.03% growth.
Revenue (ttm)
$11.24B
Revenue Growth
+5.72%
P/S Ratio
0.77
Revenue / Employee
$299,840
Employees
37,500
Market Cap
8.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.24B | 608.00M | 5.72% |
| Dec 31, 2024 | 10.64B | 276.00M | 2.66% |
| Dec 31, 2023 | 10.36B | 303.00M | 3.01% |
| Dec 31, 2022 | 10.06B | -2.09B | -17.20% |
| Dec 31, 2021 | 12.15B | 473.00M | 4.05% |
| Dec 31, 2020 | 11.67B | 311.00M | 2.74% |
| Dec 31, 2019 | 11.36B | 263.00M | 2.37% |
| Dec 31, 2018 | 11.10B | 515.00M | 4.87% |
| Dec 31, 2017 | 10.58B | 421.00M | 4.14% |
| Dec 31, 2016 | 10.16B | 195.00M | 1.96% |
| Dec 31, 2015 | 9.97B | -751.00M | -7.01% |
| Dec 31, 2014 | 10.72B | 1.31B | 13.87% |
| Dec 31, 2013 | 9.41B | -4.52B | -32.46% |
| Dec 31, 2012 | 13.94B | 43.00M | 0.31% |
| Dec 31, 2011 | 13.89B | 1.05B | 8.18% |
| Dec 31, 2010 | 12.84B | 281.00M | 2.24% |
| Dec 31, 2009 | 12.56B | 214.00M | 1.73% |
| Dec 31, 2008 | 12.35B | 1.09B | 9.63% |
| Dec 31, 2007 | 11.26B | 885.00M | 8.53% |
| Dec 31, 2006 | 10.38B | 529.00M | 5.37% |
| Dec 31, 2005 | 9.85B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Solventum | 8.33B |
| Avantor | 6.55B |
| Bausch + Lomb | 5.10B |
| The Cooper Companies | 4.15B |
| Hologic | 4.13B |
| Align Technology | 4.03B |
| AptarGroup | 3.78B |
| West Pharmaceutical Services | 3.07B |
BAX News
- 4 days ago - These 20 stocks in the S&P 500 fell hardest during March - Market Watch
- 5 days ago - Baxter Introduces the IV Verify Line Labeling System, an Automated Solution to Improve IV Labeling in Healthcare Settings - Business Wire
- 9 days ago - Baxter to Host Annual Meeting of Stockholders in Virtual Format - Business Wire
- 10 days ago - Pet Partners and the Baxter Foundation Expand Therapy Animal Programs to Support 100,000 Patients and Healthcare Workers in Two-Year Pilot - PRNewsWire
- 11 days ago - EU regulator warns of shortage in Baxter's cancer treatment until early 2027 - Reuters
- 19 days ago - Baxter Announces CFO Transition - Business Wire
- 24 days ago - Baxter International Inc. (BAX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Sticking With Baxter At The Lows - Seeking Alpha